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Abstract
CD1d molecules are MHC class I-like molecules that present glycolipids to iNKT cells. The
highly conserved interaction between CD1d:α-Galactosylceramide (αGC) complexes and
the iNKT TCR not only defines this population of αβ T cells but can also be used for its direct
identification. Therefore, CD1d oligomers are a widely used tool for iNKT cell related investi-
gations. To this end, the lipid chains of the antigen have to be inserted into the hydrophobic
pockets of the CD1d binding cleft, often with help of surfactants. In this study, we investi-
gated the influence of different surfactants (Triton X-100, Tween 20, Tyloxapol) on in vitro
loading of CD1d molecules derived from four different species (human, mouse, rat and cot-
ton rat) with αGC and derivatives carrying modifications of the acyl-chain (DB01-1, PBS44)
and a 6-acetamido-6-deoxy-addition at the galactosyl head group (PBS57). We also com-
pared rat CD1d dimers with tetramers and staining of an iNKT TCR transductant was used
as readout for loading efficacy. The results underlined the importance of CD1d loading effi-
cacy for proper analysis of iNKT TCR binding and demonstrated the necessity to adjust
loading conditions for each oligomer/glycolipid combination. The efficient usage of surfac-
tants as a tool for CD1d loading was revealed to be species-specific and depending on the
origin of the CD1d producing cells. Additional variation of surfactant-dependent loading effi-
cacy between tested glycolipids was influenced by the acyl-chain length and the modifica-
tion of the galactosyl head group with PBS57 showing the least dependence on surfactants
and the lowest degree of species-dependent differences.
Introduction
CD1 molecules belong to a non-polymorphic family of non-classical MHC class I molecules
(MHC Ib molecules) [1, 2]. All characterized members of the CD1 family are structurally
related to MHC class I molecules and have been subcategorized into group 1 (CD1a-c), 2
(CD1d) and 3 (CD1e) [3, 4]. While all CD1 molecules of group 1 and 2 are known to present
lipid antigens to T cells, CD1e rather enhances or modulates antigen-loading of the other CD1
molecules [5]. In contrast to humans and many other species, rodents possess CD1d as the
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only CD1 gene [6, 7]. The α1 and α2 domains of CD1d form an antigen binding cleft substan-
tially different from that of MHC class I molecules: Accessible through a single narrow portal
(F’ portal), it is located between both helices where two deep hydrophobic pockets (A’ and F’)
are formed beneath the surface of the CD1d molecule [8–10]. This allows insertion of hydro-
phobic chains and therefore lipid antigen presentation. In this way CD1d of most species is
able to present antigens to Type 1 NKT cells (iNKT cells), a “non-conventional” αβ T cell sub-
population [11–15]. This distinct population can be defined by the highly conserved interac-
tion between its semi-invariant iNKT TCR (Vα14/Jα18 paired with Vβ8.2 in mice and Vα24/
Jα18 paired with Vβ11 in human) and the cerebroside α-Galactosylceramide (αGC) presented
by CD1d [16–20]. A synthetic form of αGC known as KRN7000 is the first characterized and
one of the strongest known antigens for iNKT cells. The galactose head group of KRN7000 is
α-anomerically linked to ceramide containing a phytosphingosine backbone and a C26:0 acyl
chain. During the binding of iNKT TCRs to CD1d molecules presenting αGC, the acyl and
sphingosine chains are inserted into the A’ and F’ pockets of CD1d, respectively, while the
polar head group protrudes above the antigen binding cleft to make direct contacts with the
iNKT TCR [11–14].
This lineage-defining interaction of the iNKT TCR itself allows a specific and direct identifi-
cation of iNKT cells, and made glycolipid loaded CD1d oligomers an indispensable tool for
iNKT-cell related investigations [21–24]. Still, the utility of such reagents strongly depends on
effective in vitro loading with defined lipid antigens, which is prerequisite of high affinity bind-
ing of the semi-invariant iNKT TCR. In vivo, CD1d is initially loaded with self-lipids in the ER,
facilitated by the microsomal triglyceride transfer protein (MTP), while lipid exchange mostly
takes place in acidic compartments of the cell and is realized by different classes of proteins,
such as CD1e and saposins [6, 25, 26]. In vitro loading of CD1d oligomers is predominantly
performed in the presence of surfactants, which facilitate the insertion of the hydrophobic lipid
chains into the CD1d binding cleft within an aqueous solution. Previous studies could show
how length and structure of the hydrophobic chains influence CD1d loading and therefore the
usefulness of CD1d tetramers [27]. The use of different surfactants for in vitro loading of CD1d
oligomers has been described, but published studies have used CD1d molecules originating
from different species whose production followed different protocols [21–23, 27, 28]. In the
current study, we have compared loading of CD1d-mouse-IgG1 heavy chain based dimer con-
structs containing CD1d sequences from human, mouse, rat and cotton rat produced under
the same protocol in our laboratory [29, 30] as well as rat CD1d dimers and tetramers. We put
focus on the usability of different surfactants in loading of CD1d from different species with
structurally diverse αGC derivatives under conditions typically used for in vitro loading of
CD1d. We found that efficacy of in vitro loading was strongly affected by the different surfac-
tants dependent on species-origin of CD1d and type of CD1d producing cell, and modulated
by the acyl chain length of the respective glycolipid. In addition, modification of the hydro-
philic part of the glycolipid PBS57 allowed its loading without usage of surfactants. Overall,
our findings not only demonstrate the pivotal role of CD1d loading efficacy for efficient detec-
tion of cell surface expressed iNKT TCR but also the requirement of matching loading condi-
tions and CD1d oligomer/glycolipid combinations.
Materials and Methods
Cloning and expression of rat/mouse iNKT TCR
Cloning of mouse AV14S1A2 TCRα chain as well as rat BV8S4-like (CDR2+4) β chain has
been described in [31] and [32] respectively. A93G mutation of mouse AV14S1A2 TCRα
chain has been described in [30]. Mouse iNKT TCRα as well as rat β chain were transduced
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retrovirally and expressed in BW r/mCD28 cells, which are BW58 TCR-negative mouse
hybridoma cells transduced with a chimeric rat/mouse CD28 molecule as described in [33].
Cell surface expression of transduced TCR was analyzed by staining with biotinylated anti-
mouse CD3εmAb (BD Pharmingen), revealed by Allophycocyanin conjugated streptavidin
(BD Pharmingen). Cells were sorted using a FACS Aria III (BD Biosciences) machine.
Cell culture
BW r/mCD28 iNKT TCR cells were cultured in RPMI 1640 medium supplemented with 10%
FCS, 1 mM sodium pyruvate, 2.05 mM glutamine, 0.1 mM nonessential amino acids, 25 μM β-
mercaptoethanol, penicillin (100 U/ml) and streptomycin (100 μg/ml) at 310.15 K with 5%
CO2 and an H2O-saturated atmosphere.
Lipids and sufactants
α-Galactosylceramide (αGC) was purchased from Avanti Polar Lipids. PBS44 and PBS57 are
described in [34, 35]. DB01-1 is described in [27]. All lipids used in this study were dissolved in
100% Dimethylsulfoxide at a concentration of 500 μM by sonication for 5 min at RT. All sur-
factants used in this study were purchased from Sigma-Aldrich (St. Louis, MO, USA) and
diluted 1:100 in PBS.
Cloning and production of CD1d Dimer constructs
Generation of human, mouse, rat [29, 30] and cotton rat CD1d dimers [36] was performed as
described previously for mouse CD1d dimers [37]. Modification such as the use of rat
β2-microglobulin transduced J558L cells for rat CD1d dimer production and construction of
the CD1d dimer expression vectors have been performed as described in [38]. In short, CD1d
extracellular domains α1–3 were amplified by PCR and cloned into the MluI/XhoI sites of the
pXIg vector [39], thereby generating a CD1d/mIgG heavy chain chimeric construct with CD1d
inserted between mIgG heavy cain leader and variable sequences. CD1d dimer gene constructs
were expressed by J558L mouse myeloma cells [40] and purified from culture supernatants as
described [38]. CD1d dimers were stored at 4°C in PBS containing 0.02% NaN3.
Rat CD1d tetramers
Unloaded PE conjugated rat CD1d tetramers were generated from CD1d monomers and rat
β2-microglobulin produced by human embryonic kidney derived 293T cells (Rick Willis, per-
sonal communication) and obtained from the NIH Tetramer Core Facility, Emory University
Vaccine Center, 954 Gatewood Road Atlanta, GA 30329, USA.
Loading of CD1d oligomers
CD1d oligomers (at a final concentration of 250 μg/mL in PBS) were loaded with 40x molar
excess of lipid (dissolved at 500 μM in DMSO; final amount of DMSO in loading mixture:
7.5%) by incubation for 22 h at 37°C in the presence of 0.05% surfactant or the corresponding
amount of PBS. As negative control, CD1d dimers were incubated with the corresponding
amount of DMSO without lipid (vehicle loading).
Flow cytometry
Cells were analyzed on a FACSCalibur machine (BD Biosciences) using FlowJo software
(TREE STAR Data analysis software). CD1d oligomer staining was carried out at room temper-
ature for 30 min in 100 μl of sample containing 105 iNKT TCR transductant cells suspended in
Species Specific Differences of CD1d Oligomer Loading In Vitro
PLOSONE | DOI:10.1371/journal.pone.0143449 November 24, 2015 3 / 13
FACS buffer (PBS pH 7.4, BSA 0.1%, 0.01% NaN3). Bound CD1d dimers were detected with
PE labeled donkey F(ab0)2 fragment anti-mouse IgG (H+L) with minimal cross-reactivity
towards rat and other species serum proteins (Dianova), referred hereafter as DαM. After incu-
bation with DαM, nonspecific binding to the DαMAb was blocked with IgG from mouse
serum and biotinylated anti-mouse CD3ε (clone 145-2C11) was added. Biotinylated antibodies
were detected with Allophycocyanin conjugated streptavidin (BD Pharmingen).
Statistical analysis
CD1d dimer staining was visualized and statistically analyzed using Prism (GraphPad).
Results
Production of CD1d dimers and in vitro loading analysis
Human, mouse and rat CD1d dimer constructs used in this study have already been described
in the literature [29, 30]. Also included in the analysis were CD1d dimers of cotton rat which
have recently been generated in our laboratory [36]. Such dimers allowed the characterization
of iNKT cells from this species. As found for other muroid rodents cotton rat possesses CD1d
as single member of the CD1 family with high sequence homology of its extracellular domain
to CD1d of mouse, rat and human (Fig 1A) [36]. The extracellular part of CD1d (Fig 1A;
domains α1–3) was cloned 5’ of the V segment of a rearranged mouse IgG1 heavy chain.
Cloned CD1d-mIgG1-HC constructs were used for transfection of rat β2-microglobulin trans-
duced J558L mouse B cell lymphoma cells lacking Ig heavy chain expression but capable of
producing mouse Ig lambda light chain as well as mouse β2-microglobulin. Supernatant of
resulting CD1d-mIgG dimer producing cell lines was collected and dimers were purified. For
loading of CD1d, 250 μg/mL dimers in PBS were incubated with 40 times molar excess of lipid
antigen o.n. in presence of 0.05% surfactant or the corresponding amount of PBS at 37°C (Fig
1B). Lipid antigens were used at 500 μM in DMSO. Vehicle loading of CD1d dimers as control
was performed using corresponding amount of pure DMSO.
We compared the efficacy of CD1d in vitro loading with αGC, DB01-1, PBS44 and PBS57
without adding surfactant or in presence of Triton X-100, Tween 20 and Tyloxapol. After in
vitro loading with respective lipid antigens, CD1d dimers were directly used for staining of
transduced mouse T-cell hybridoma cells expressing an iNKT TCR as indicator of effective
loading with the respective lipid antigen (Fig 1C). In order to increase comparability of the
CD1d binding assays all experiments were performed with the same TCR-transductant. Since
CD1d molecules from different species vary considerably with respect to cross-species reactiv-
ity (e.g. mouseCD1d binds only poorly to rat iNKT TCR [30]) a transductant with a canonical
mouse AV14/AJ18 iNKT TCRα chain paired with a rat BV8S4 iNKT TCRβ chain was used
which binds CD1d of tested species with similar efficacy. Binding of CD1d dimers was detected
by staining with PE conjugated donkey anti-mIgG F(ab’)2 fragment. Staining was performed
three times independently using CD1d dimers derived from two independent in vitro loadings.
Resulting staining is presented as relative to anti-mCD3 staining to compensate for variation in
surface TCR expression.
Fig 1C shows structural features of all tested glycolipids. αGC, DB01-1 and PBS44 have an
identical head group but differ at the acyl chain: Compared to αGC, DB01-1 is characterized
by a shortened acyl-chain (C26:0 -> C24:0) and compared to DB01-1, PBS44 by an additional
C-C double bond introduced between C15 and C16 of the acyl chain (C24:0 -> C24:1). PBS57
was the only tested αGC derivative with a modification at the sugar head group: PBS44 and
PBS57 share an identical acyl chain (C24:1) but PBS57 bears an additional amide group at the
C6 atom of the galactose head group.
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Fig 1. Experimental setup. (A) α1 and α2 domain amino acids of CD1d molecules used in this study. Alignment was performed using BioEdit. Human:
GenBank BC027926.1, Mouse: GenBank AK002582.1, Rat: GenBank AB029486.1, Cotton Rat: GenBank KM_267558. (B) In vitro loading analysis of CD1d
dimers presented as schematic overview. (C) Scheme explaining the emergence of different saturating curves depending on loading efficacy of dimers.
Upper panel: Inefficient loading leads to low proportion of functionally bivalent CD1d dimers, Lower panel: Efficient loading leads to high proportion of
functional bivalent CD1d dimers. Drawing represents several step flow cytometry analysis of incubation/wash/detection. (D) Structural features of all
glycolipids used in this study.
doi:10.1371/journal.pone.0143449.g001
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All surfactants tested within this study have been described for loading of CD1d oligomers
[21–23, 27, 28]. All are non-ionic but differ in critical micelle concentrations (CMC) and
hydrophilic lipophilic balances (HLB) (S1 Table).
Therefore, by testing not only successful association of lipids with CD1d but measuring the
binding capabilities of CD1d dimers, we could directly analyze their functionality for iNKT cell
related investigations and the influence of loading conditions on the usage of CD1d oligomers
as a research tool.
Species-specific differences in surfactant efficacy during loading of
CD1d
Depending on the origin of CD1d, the usage of different surfactants led to substantial differ-
ences in αGC loading efficacy (Fig 2 and S1 Fig).
For loading with αGC, surfactants were needed to effectively load CD1d of all species. The
surfactants behaved similarly with respect to loading of human CD1d but differed in efficacy of
loading CD1d of the other species. Triton X-100 was the only surfactant which led to effective
αGC-loading of CD1d from all species. Tween 20 was most efficient with respect to loading of
mouse CD1d and Tyloxapol for loading of cotton rat CD1d. In this way, all the tested CD1d
differed with respect to the surfactants enabling effective αGC loading.
In comparison to αGC the loading of CD1d from human, mouse and rat with DB01-1 was
less effective. For mouse and rat CD1d, surfactant preferences were diminished, while opposite
effects could be seen for human and cotton rat CD1d.
In comparison to DB01-1, loading of CD1d from all species with PBS44 was more effective
and less depending on the choice of surfactant. But the presence of surfactant was still needed
for loading of all CD1d species with both DB01-1 and PBS44.
PBS57 allows loading without surfactant
In general, loading of PBS57 was more effective than loading of any other αGC derivative (Fig
2). Compared to PBS44, loading of PBS57 led to diminished preferences in surfactant usage
and changed preferences for rat CD1d where Tyloxapol and Tween20 became more effective
than Triton X-100. Interestingly, in contrast to αGC, DB01-1 and PBS44, loading of PBS57 did
not require the presence of any surfactant for effective loading of CD1d regardless of species
origin. Indeed, for all species the loading efficacy of PBS57 without usage of surfactant was
comparable to loading in presence of Triton X-100.
Glycolipid depending differences in loading efficacy
We also compared the maximum binding observed with every combination of CD1d dimer
and glycolipid tested in this study independent of the surfactant used for loading (Fig 3A). This
analysis showed a similar pattern of glycolipid dependent differences in loading efficacy for
human, mouse and rat CD1d: the most effective loading of PBS57 led to the highest binding of
CD1d dimers, followed by αGC, PBS44 and DB01-1. We also calculated the maximum binding
of αGC, PBS44 and DB01-1 as relative to the maximal binding of PBS57 for each species sepa-
rately to ignore species-mismatch and TCRα position 93 related CD1d-intrinsic effects [30] on
binding of the specific TCR (Fig 3B). In this way the glycolipid depending pattern becomes
even more clearly. Statistical analysis showed significance for differences in maximum binding
between αGC and DB01-1 as well as between PBS57 and both PBS44 and DB01-1 in human,
mouse and rat CD1d (S2 Table). The highest maximum binding of cotton rat CD1d dimers
was also observed with PBS57, showing a significantly higher maximum binding than all other
tested glycolipids. Loading of cotton rat CD1d with PBS44 was more effective compared to
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Fig 2. In vitro loading analysis of CD1d dimers.CD1d dimers were incubated with 40x molar excess of indicated glycolipid in presence of 0.05% of
indicated surfactant or without surfactant o.n. at 37°C. After in vitro loading, the indicated amount of CD1d dimers was used for staining of 105 iNKT TCR
transduced cells, dimer binding was revealed by staining with PE labeled donkey F(ab0)2 fragment anti-mouse IgG (H+L). Binding presented as relative
staining, i.e. ratio between geometric means of CD1d dimer and CD3 antibody staining was performed simultaneously. In total, staining was performed three
times independently using oligomers derived from two independent loadings. Hierarchy of surfactant efficacy between experiments is shown in S1 Fig. Note
that scales differ in order to facilitate visualization different hierarchies of binding caused by the different surfactants.
doi:10.1371/journal.pone.0143449.g002
Fig 3. Maximum binding of differently loaded CD1d dimers. (A+B) Highest relative staining reached with
each CD1d dimer loaded with indicated glycolipid as presented in Fig 2. Presented (A) as absolute or (B) as
relative to the highest value reached for each CD1d. Human CD1d: Binding maxima are for all glycolipids are
reached with Tyloxapol as surfactant. Mouse CD1d: Binding maxima with αGC and PBS57 are reached with
Tween 20, forDB01-1 with Triton X-100 and for PBS44 with Tyloxapol. Rat CD1d: Binding maxima for αGC,
DB01-1 and PBS44 are reached with Triton X-100, and for PBS57 with Tyloxapol. Cotton Rat: All maxima
reached using Tyloxapol. Statistical analysis can be found in S2 Table. Hierarchy of surfactant efficacy
between experiments are shown in S1 Fig. Data were computed from results shown in Fig 2.
doi:10.1371/journal.pone.0143449.g003
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αGC and DB01-1, but only differences between PBS44 and DB01-1 were found to be statisti-
cally significant.
Comparison of rat CD1d dimer and rat CD1d tetramer loading
Since CD1d tetramers are widely used for studying iNKT cells, we went on to compare loading
properties of rat CD1d dimers derived from our own production in mouse myeloma cells and
rat CD1d tetramers provided by the NIH tetramer core facility produced from CD1d mono-
mers in human embryonic kidney derived 293T cells and with rat β2-microglobulin (Fig 4).
There were two main differences in loading of rCD1d tetramers with αGC (derivatives) com-
pared to rCD1d dimers: a) Preferences in the usage of specific surfactants were diminished.
Only Tween 20 showed lower loading efficacy for αGC and DB01-1, while loading of PBS44
and PBS57 remained unaffected from the choice of surfactant. b) In comparison to the mye-
loma produced CD1d-dimers, Tween20 showed lower efficacy in αGC loading than Tyloxapol
which was essentially as effective as Triton X100. c) General loading efficacy of DB01-1 was
higher than that of αGC while loading efficacy of PBS57 was lower than that of all other αGC
derivatives. Still, PBS57 was the only tested derivative that could be loaded without the pres-
ence of any surfactant.
Discussion
The maximum iNKT TCR binding of αGC, DB01-1, PBS44 or PBS57 loaded CD1d dimers
from mouse, rat or cotton rat differed strongly at saturating concentrations. A scheme illustrat-
ing the underlying mechanism as proposed by us is depicted in Fig 1C. In vitro loading of
CD1d dimers with a defined lipid x results in a mixture of three different compounds: CD1d
dimers of type a) no CD1d molecule presenting lipid x, type b) one CD1d molecule presenting
lipid x and type c) two CD1d molecules presenting lipid x. Hereby, the efficacy of the loading
process (depending on the surfactant) alters the ratio between those three compounds. After in
vitro loading, a defined quantity of CD1d dimers is incubated with the iNKT TCR carrying
cells. CD1d dimers of type a (unloaded), which lack the specific antigen will not be able to bind
any iNKT TCR. CD1d dimers of type b (one CD1d molecule loaded) will be able to bind single
iNKT TCRs, CD1d dimers of type c (both CD1d molecules loaded) will be able to bind two
iNKT TCRs at once. The different avidity of type b and c dimers results in different off rates,
thereby a higher proportion of type b dimers dissociates and is replaced by dimers of type b or
type c during incubation. Washing the cells massively reduces the ratio between of free and cell
bound dimers hence the different valency of CD1d:glycolipid complexes will directly result in a
variant total amount of CD1d dimers to be detected at the cell surface as consequence of the
ratio between type b (high off-rate) and type c (low off-rate). In this way the ratio between type
b and type c in solution after in vitro loading defines the point of saturation for the binding
curve. In principle this problem applies to all types of TCR-staining using oligomers of com-
plexes of antigens- and antigen-presenting molecules but is especially prominent for CD1:gly-
colipid complexes given the difficulty to assess proper loading of the molecules as it has been
show for CD1d in greater detail previously [41].
The relative efficacy of different surfactants in CD1d loading with αGC and derivatives
depended on species or cell type origin of the CD1d. During the loading process, the hydropho-
bic part of the lipid antigen has to be inserted via the F’ portal into the hydrophic pockets (A’
and F’) of the CD1d antigen binding cleft. Since the preferences in surfactant usage were
mainly dependent on the origin of CD1d, it can be assumed that differences within the F’ portal
or the antigen binding pockets between the different CD1d molecules would be responsible for
this finding. Those CD1d dependent characteristics of lipid loading efficacy were found also to
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be altered using rat CD1d tetramers instead of rat CD1d dimers. While basic structural features
of CD1d heavy chain should not differ between both reagents, the fact that they are produced
in different cell types is likely to contribute to those differences. The access to the hydrophobic
pockets is essential for the loading of lipid antigens. During the folding process of CD1d, an
undefined variety of self lipids are loaded into the CD1d binding cleft. Replacement of those
endogenous antigens requires removal of the endogenous lipid and insertion of the defined
lipid present in excess within the solvent. Differences in glycosylation may well contribute to
the properties of the F’ portal influencing loading of self-lipids, the accessibility of the hydro-
phobic pockets and the requirements for surfactants facilitating the in vitro lipid exchange.
Common for all CD1d molecules and also the analyzed rCD1d tetramer was the lack of
effective loading with αGC, DB01-1 or PBS44 in the absence of any surfactant. In contrast to
this, loading of all tested oligomers with PBS57 was possible without addition of any surfactant.
In other words, the general need for the usage of surfactants did depend on the structure of the
antigen itself, not on the origin of the CD1d molecule. Not only the accessibility of the CD1d
hydrophobic pockets is crucial during the lipid exchange, but also the accessibility of the
hydrophobic chains which have to be inserted. Glycolipids such as αGC and its derivatives are
amphiphatic molecules, which will form aggregates like micelles within an aqueous solution if
present above a critical concentration. In such aggregates, the hydrophobic chains of the mole-
cules will orientate to the inner phase, which is separated from the aqueous solution by the
hydrophilic head groups. The formation of such aggregates can be expected to hamper the
loading process since the hydrophobic chains of the single lipid are no longer easily accessible.
The presence of surfactants can alter the properties of such aggregates thereby improving the
accessibility of the hydrophobic chains of single lipids and facilitating the lipid exchange. But
the solubility of lipids can also be altered by structural changes influencing the hydrophilic-
Fig 4. In vitro loading analysis of rat CD1d tetramers. PE conjugated CD1d tetramers were incubated with
40x molar excess of indicated glycolipid in presence of 0.05% indicated surfactant or without surfactant o.n.
at 37°C. After in vitro loading, the indicated amount of CD1d tetramers was used for staining of 105 iNKT TCR
transduced cells. Binding presented as relative staining, i.e. ratio between geometric means of CD1d
tetramer and CD3 antibody staining performed simultaneously. In total, staining was performed three times
independently using oligomers derived from two independent loadings. Hierarchy of surfactant efficacy
between experiments is shown in S1 Fig.
doi:10.1371/journal.pone.0143449.g004
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lipophilic balance. The shortening of the acyl chain (αGC (26:0) to DB01-1 (24:0)) as well as
the introduction of a double bond resulting in a conformational change of the acyl chain
(DB01-1 (24:0) to PBS44 (24:1)) did not alter the solubility of the glycolipid in a way that allows
loading independent of surfactants. In previous studies it was shown that shortening the 26:0
acyl chain of the aGC to a C20:2 acyl chain is needed for effective loading without usage of Tri-
ton X-100 [27]. Here we could see the same effect for the addition of an amide group at the C6
of the galactose of αGC without further modification of the lipid chains. Such modifications of
the polar head group can lead to an altered HLB and therefore increase the lipid solubility,
improving its accessibility as a free monomer, available for loading into the CD1d binding
cleft. Another parameter which has also to be considered is the role of the surfactants in facili-
tating the dissociation of the endogenous glycolipids from the CD1d molecule. Furthermore,
since the dynamics in formation of (mixed) micelles, the interaction between different amphi-
phatic molecules and thus its availability in an aqueous solution are influenced by the respec-
tive concentrations, temperature and pH-value, further and more extensive analysis is needed
for a better understanding of the physicochemical basis of this process as well as to determine
optimal conditions for the loading of any CD1d molecule/glycolipid combination.
The tetramers and dimers used in this study differ in three major points: 1) Tetramers have
a higher maximum valency of TCR binding molecules, namely three [42]. 2) Tetramers are
directly labeled thus one of the washing step allowing dissociation of insufficiently loaded olig-
omers is missing (Fig 1C). 3) Both are produced in different cells. The first two points explain
the partial leveling of binding. More interestingly is that surfactants differentially affect loading
of CD1d dimers and tetramers, especially in case of αGC: Dimers loaded in presence of Tween
20 bind slightly better than those loaded in presence of Tyloxapol while tetramers loaded in
presence of Tyloxapol bind about three time better than those loaded in presence of Tween 20.
Since in either case the same CD1d heavy chain amino acid sequences were used for produc-
tion, variations between the CD1d producing cells must account for this effect. As most likely
reason we see differences between the endogenous lipids which needed to be replaced by the
glycolipids during loading. This can be caused by either different compositions of human vs
mouse endogenous glycolipids or by differences in the intracellular lipid loading machinery.
All together, those results show the importance of proper CD1d in vitro loading for iNKT
TCR binding studies and demonstrate how the efficacy of different surfactants used at typical
conditions strongly depends on species-origin as well as production of CD1d, and how it is fur-
ther influenced by the structural diversity of the glycolipids to be loaded. This clearly illustrates
the need to carefully adjust in vitro loading conditions for every CD1d/glycolipid combination
to obtain comparable results in iNKT binding studies which include more than one CD1d or
glycolipid.
Supporting Information
S1 Fig. Hierarchy of surfactant efficacy at binding maximum. Comparison of maximum
binding detected for differently loaded CD1d oligomers in three independent experiments
shown in Fig 2. L1 = staining from loading reaction 1, L2a/b = staining a or b from loading
reaction 2. The column on the very right summarizes the results of the left columns with an
identical scale for the Y-axis. Error bars indicate SD.
(DOC)
S1 Table. Surfactants used in this study. CMC = critical micelle concentration, HLB = hydro-
philic-lipophilic balance
(DOC)
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S2 Table. Statistical analysis of CD1d maximum binding. (A-D) Analysis of data as pre-
sented in Fig 3A. Given Values beneath respective glycolipid indicate mean ± standard devia-
tion of respective staining, numbers in brackets indicate p values. ns: p> 0.05, p< 0.05,
p< 0.005, p< 0.0005, unpaired t-test.
(DOC)
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